CVS Health Return on Tangible Equity 2010-2024 | CVS

Current and historical return on tangible equity values for CVS Health (CVS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
CVS Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-06-30 $7.19B $-44.47B -15.92%
2024-03-31 $7.32B $-45.89B -15.87%
2023-12-31 $8.34B $-43.87B -18.81%
2023-09-30 $8.63B $-46.38B -20.95%
2023-06-30 $2.97B $-48.38B -7.87%
2023-03-31 $4.09B $-38.85B -12.27%
2022-12-31 $4.31B $-31.18B -13.46%
2022-09-30 $3.37B $-32.23B -10.41%
2022-06-30 $8.38B $-31.19B -25.49%
2022-03-31 $8.13B $-33.46B -23.86%
2021-12-31 $8.00B $-32.77B -22.55%
2021-09-30 $7.58B $-34.05B -20.19%
2021-06-30 $7.20B $-36.07B -18.21%
2021-03-31 $7.40B $-39.03B -17.81%
2020-12-31 $7.18B $-40.99B -16.47%
2020-09-30 $7.95B $-42.16B -17.48%
2020-06-30 $8.26B $-43.93B -17.37%
2020-03-31 $7.22B $-47.25B -14.57%
2019-12-31 $6.63B $-48.70B -12.93%
2019-09-30 $4.47B $-50.27B -8.38%
2019-06-30 $4.33B $-52.05B -9.97%
2019-03-31 $-0.17B $-54.22B 0.51%
2018-12-31 $-0.59B $-56.66B 2.58%
2018-09-30 $3.11B $-10.76B -24.94%
2018-06-30 $3.01B $-11.93B -21.58%
2018-03-31 $6.67B $-12.83B -43.62%
2017-12-31 $6.62B $-14.39B -40.05%
2017-09-30 $5.04B $-16.60B -30.25%
2017-06-30 $5.30B $-17.34B -32.15%
2017-03-31 $5.12B $-17.81B -31.22%
2016-12-31 $5.32B $-14.93B -33.41%
2016-09-30 $5.11B $-15.83B -32.17%
2016-06-30 $4.81B $-17.06B -31.50%
2016-03-31 $5.16B $-15.83B -46.14%
2015-12-31 $5.24B $-14.78B -70.30%
2015-09-30 $5.06B $-13.46B -135.19%
2015-06-30 $4.76B $-0.67B -1352.84%
2015-03-31 $4.74B $-0.89B -2978.62%
2014-12-31 $4.64B $0.05B 5495.86%
2014-09-30 $4.59B $0.10B 850.42%
2014-06-30 $4.89B $0.10B 439.36%
2014-03-31 $4.77B $0.09B 270.62%
2013-12-31 $4.59B $1.87B 207.43%
2013-09-30 $4.44B $2.40B 209.25%
2013-06-30 $4.20B $2.70B 247.46%
2013-03-31 $4.04B $1.90B 284.10%
2012-12-31 $3.86B $1.51B 275.12%
2012-09-30 $3.81B $0.69B 261.30%
2012-06-30 $3.68B $1.60B 237.94%
2012-03-31 $3.53B $1.82B 230.92%
2011-12-31 $3.46B $1.72B 202.34%
2011-09-30 $3.42B $1.03B 185.86%
2011-06-30 $3.36B $1.53B 181.32%
2011-03-31 $3.37B $2.56B 219.23%
2010-12-31 $3.43B $2.25B 384.09%
2010-09-30 $3.45B $1.09B 1076.23%
2010-06-30 $3.66B $0.25B 34083.72%
2010-03-31 $3.73B $-0.02B 9150.92%
2009-12-31 $3.70B $-0.04B -3820.16%
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $68.749B $357.776B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Walgreens (WBA) United States $8.067B 3.24
Herbalife (HLF) Cayman Islands $0.830B 4.38
China Jo-Jo Drugstores Holdings (CJJD) China $0.015B 0.00
GNC Holdings (GNC) United States $0.000B 0.00